Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual diabetes coaching could ease daily burden for type 1 patients

NCT ID NCT05756829

Disease control Sponsor: Unity Health Toronto Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether frequent, short virtual visits with diabetes educators can help adults with type 1 diabetes improve their blood sugar control. 580 participants will receive video check-ins every 1-3 weeks for 6 months, plus access to online education tools. The goal is to make diabetes management easier and more effective without requiring extra in-person clinic visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual health care intervention (frequent video visits with certified diabetes educators plus online education platform)
What this could lead to
If successful, this could offer a more convenient and effective way for people with type 1 diabetes to manage their condition, potentially improving blood sugar control without extra in-person visits.
What could go wrong
This is a mid-sized trial testing a behavioral intervention, not a new drug or cure. Results may vary by individual, and the benefit over standard care might be modest. The study is open-label, so expectations could influence outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 580 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2023

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Outpatients ≥18 years of age 2. Physician diagnosis of type 1 diabetes 3. Currently on an insulin pump or using multiple daily insulin injections. 4. HbA1c ≥ 7.5% on most recent laboratory report or estimated from CGM/FGM\* report, within the last 4 months \*14 day look back window, with a wear rate of 70%, based on Estimated A1c or Glucose management Indicator (GMI) 5. Has access to a mobile device or computer/tablet with a video camera 6. Seen for at least one visit in the previous 6 months by participating certified diabetes educator at the selected diabetes clinic OR If a transitioning patient: Currently enrolled in a diabetes program below AND had at least one visit or touch-point prior in the previous 6 months by participating certified diabetes educator at on of our participating diabetes clinics 7. OHIP coverage 8. Currently using an active email address or be willing to obtain an email address 9. Has consistent and reliable access to internet 10. Willing and able to comply with scheduled in-person and virtual visits for 6 month intervention period Exclusion Criteria: 1. Diagnosed with non-Type 1 diabetes 2. Unable to use a computer/tablet or mobile phone 3. Pregnant 4. On dialysis 5. Unable to fluently speak or read English (self-reported)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE1DIABETES

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Charles H. Best Diabetes Centre

    RECRUITING

    Whitby, Ontario, L1M 1Z5, Canada

  • Mackenzie Health

    RECRUITING

    Richmond Hill, Ontario, L4C 4Z3, Canada

  • Mount Sinai Hospital

    RECRUITING

    Toronto, Ontario, M5G 1X5, Canada

  • St. Joseph's Health Centre, Unity Health Toronto

    RECRUITING

    Toronto, Ontario, M6R 1B5, Canada

  • St. Michael's Hospital, Unity Health Toronto

    RECRUITING

    Toronto, Ontario, M5B 1W8, Canada

  • Sunnybrook Health Sciences Centre

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

  • Toronto General Hospital

    RECRUITING

    Toronto, Ontario, M5G 2C4, Canada

  • Waterloo Regional Health Network

    RECRUITING

    Kitchener, Ontario, N2G 1G3, Canada

  • Women's College Hospital

    NOT_YET_RECRUITING

    Toronto, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.